(OCUL) |
| 0 (0%) 01-13 19:30 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 16.44 |
| Resistance 1: | 14.01 |
| Pivot price: | 11.83 |
| Support 1: | 10.08 |
| Support 2: | 8.39 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.430 |
| Book Value | 1.480 |
| PEG Ratio | 0.00 |
| Gross Profit | -0.646 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -472.35 |
| Return on Assets (ttm) | -36.6 |
| Return on Equity (ttm) | -81.8 |
Company news
Sat, 10 Jan 2026
Did Focus on AXPAXLI’s Pipeline Potential Just Shift Ocular Therapeutix's (OCUL) Investment Narrative? - simplywall.st
Fri, 09 Jan 2026
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Stock Retreats 29% But Revenues Haven't Escaped The Attention Of Investors - Sahm
Wed, 07 Jan 2026
Is It Too Late To Consider Ocular Therapeutix (OCUL) After Recent Share Price Volatility? - Yahoo Finance
Tue, 06 Jan 2026
Assessing Ocular Therapeutix (OCUL) Valuation After Mixed Short-Term Weakness And Multi-Year Shareholder Gains - Sahm
Fri, 02 Jan 2026
Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales - The Globe and Mail
Wed, 31 Dec 2025
BofA Bullish on Ocular Therapeutix (OCUL) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
